Key performance indicators of ischaemic stroke from Chinese Stroke Center Alliance in 2018
| Key performance indicators | Relative frequency | % (95% CI) |
| Acute performance measures | ||
| Intravenous rtPA≤4.5 hours | 16 270/67 122 | 24.2 (23.9% to 24.6%) |
| Early antithrombotics | 223 740/264 348 | 84.6 (84.5% to 84.8%) |
| DVT prophylaxis | 35 321/83 605 | 42.3 (41.9% to 42.6%) |
| Discharge performance measures | ||
| Antithrombotics | 229 080/261 594 | 87.6 (87.4% to 87.7%) |
| Anticoagulants for AF | 8448/19 283 | 43.8 (43.1% to 44.5%) |
| BP lowering for HTN | 130 477/202 912 | 64.3 (64.1% to 64.5%) |
| Glucose-lowering for hyperglycaemic | 59 039/75 330 | 78.4 (78.1% to 78.7%) |
| Statin for LDL | 238 145/266 767 | 89.3 (89.2% to 89.4%) |
| Additional quality measures | ||
| Smoking cessation | 61 221/63 630 | 96.2 (96.1% to 96.4%) |
| Dysphagia screen | 214 407/269 428 | 79.6 (79.4% to 79.7%) |
| Rehabilitation | 202 787/269 428 | 75.3 (75.1% to 75.4%) |
| Summary performance measures | ||
| Composite score | 0.77±0.21 | |
| All-or-none measure | 73 017/269 428 | 27.1 (26.9% to 27.3%) |
AF, atrial fibrillation; BP, blood pressure; DVT, deep vein thrombosis; HTN, hypertension; LDL, low-density lipoprotein; rtPA, recombinant tissue plasminogen activator.